A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; pp. viii719 - viii720
Main Authors	Qin, S.K., Ren, Z.G., Meng, Z.Q., Chen, Z.D., Chai, X.L., Xiong, J.P., Bai, Y.X., Yang, L., Zhu, H., Fang, W.J., Lin, X.Y., Chen, X.M., Li, E.X., Xia, Y., Zou, J.J.
Format	Journal Article
Language	English
Published	England Elsevier Ltd 01.10.2018
Online Access	Get full text
ISSN	0923-7534 1569-8041
DOI	10.1093/annonc/mdy424.029

Loading…